Association Mechanisms Between Periodontal Diseases and Systemic Pathology
Open Access
- 2 June 2025
- journal article
- Published by Wolters Kluwer Health in West Kazakhstan Medical Journal
- Vol. 67 (2) , 162-176
Abstract
Periodontitis is a chronic inflammatory disease caused by a dysbiotic oral microbiome and an altered immune response. It affects approximately 10% of the adult population and is one of the leading causes of tooth loss. Beyond its local consequences, periodontitis is closely associated with systemic diseases, including cardiovascular disorders, type 2 diabetes, rheumatoid arthritis, osteoporosis, chronic kidney disease, Alzheimer’s disease, pneumonia, pregnancy complications, and COVID-19. The main mechanisms underlying this relationship include chronic systemic inflammation, the spread of bacteria and their toxins through the bloodstream, and the activation of immune cells capable of exacerbating inflammation in other organs. For instance, bacterial lipopolysaccharides (LPS) and periodontopathogens such as Porphyromonas gingivalis can contribute to the development of atherosclerosis, endotoxemia, and autoimmune reactions. Further clinical studies are required to establish a causal relationship and develop effective treatment strategies. A deeper understanding of these mechanisms may facilitate the development of interdisciplinary approaches to the prevention and treatment of both periodontitis and related systemic diseases.Keywords
This publication has 42 references indexed in Scilit:
- Periodontitis and periodontopathic bacteria as risk factors for rheumatoid arthritis: A review of the last 10 yearsJapanese Dental Science Review, 2023
- Clinical, immunological, and microbiological analysis of the association between periodontitis and COVID-19: a case–control studyOdontology, 2023
- Oral polymicrobial communities: Assembly, function, and impact on diseasesCell Host & Microbe, 2023
- Pathobiont-responsive Th17 cells in gut-mouth axis provoke inflammatory oral disease and are modulated by intestinal microbiomeCell Reports, 2022
- Association of periodontal therapy, with inflammatory biomarkers and complications in COVID-19 patients: a case control studyClinical Oral Investigations, 2022
- Global, regional, and national burden of periodontitis from 1990 to 2019: Results from the Global Burden of Disease study 2019Journal of Periodontology, 2022
- C3-targeted therapy in periodontal disease: moving closer to the clinicTrends in Immunology, 2021
- Oral microbiome and pregnancy: A bidirectional relationshipJournal of Reproductive Immunology, 2021
- Economic burden of periodontitis in the United States and Europe: An updated estimationJournal of Periodontology, 2021
- Baseline HbA1c Level Influences the Effect of Periodontal Therapy on Glycemic Control in People with Type 2 Diabetes and Periodontitis: A Systematic Review on Randomized Controlled TrailsDiabetes Therapy, 2021